Neuroblastoma: all 634 studies
Page 1 of 7. Open to participants first (122), then studies with results posted, then the rest; newest registration first within each.
- Prospective Multicenter Study of the Genomic, Transcriptomic, and Biological Profile of Patients With NeuroblastomaRecruitingNCT07881172
- Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory NeuroblastomaRecruitingNCT07767630Early Phase 1
- Dinutuximab-beta and Chemotherapy in Newly Diagnosed High-Risk NeuroblastomaRecruitingNCT07688252Phase 1
- Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory NeuroblastomaRecruitingNCT07635056Phase 2
- Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.Enrolling by invitationNCT07595666Not applicable
- Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid TumorsRecruitingNCT07584499Phase 1
- Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5RecruitingNCT07537400Phase 2
- Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or NeuroblastomaNot yet recruitingNCT07518654Phase 1
- Serial ctDNA and Molecular Residual Disease Monitoring in NeuroblastomaRecruitingNCT07516678
- Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory NeuroblastomaRecruitingNCT07502287Phase 1/2
- Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten WorseRecruitingNCT07437963Phase 1/2
- An Imaging Study of Anti-GD2-800CW in Patients With NeuroblastomaRecruitingNCT07399821Phase 1/2
- Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and GanglioneuroblastomaRecruitingNCT07375563Phase 3
- B7-H3.CD28Z.CART in Solid TumorsRecruitingNCT07358260Phase 1
- A Multi-Arm, Platform Trial For Relapsed NeuroblastomaRecruitingNCT07334301Phase 1/2
- Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in ChildrenRecruitingNCT07318831Phase 2
- NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + DinutuximabNot yet recruitingNCT07261241Phase 2
- NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or NeuroblastomaRecruitingNCT07211737Phase 1
- Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/ParagangliomaRecruitingNCT07195500
- Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)RecruitingNCT07172958Phase 1
- Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive MethodRecruitingNCT07141862
- Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma.Not yet recruitingNCT07111117Phase 2
- GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma.Not yet recruitingNCT07090538Early Phase 1
- Safety & Efficacy of IR-101 in Relapsed/Refractory NeuroblastomaRecruitingNCT07067346Early Phase 1
- Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of NeuroblastomaRecruitingNCT07064746
- Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory NeuroblastomaRecruitingNCT07027748Phase 1
- Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory NeuroblastomaRecruitingNCT06995872Phase 1
- DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET DysregulationsRecruitingNCT06988475Phase 2/3
- A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory NeuroblastomaNot yet recruitingNCT06948994Phase 1/2
- Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationRecruitingNCT06942039Early Phase 1
- Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M NeuroblastomaRecruitingNCT06933394Phase 2
- Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in ChinaNot yet recruitingNCT06873672
- Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid TumorsAvailableNCT06872489
- 18F-mFBG PET Imaging in the Evaluation of NeuroblastomaRecruitingNCT06852807
- Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.RecruitingNCT06836505Phase 1/2
- Resource Intervention to Support Equity (RISE) in High-Risk NeuroblastomaRecruitingNCT06831552Not applicable
- Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With NeuroblastomaRecruitingNCT06818916Not applicable
- Pencil Beam Scanning Proton Beam Radiotherapy for the Management of Abdominal NeuroblastomaNot yet recruitingNCT06804447Not applicable
- Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk NeuroblastomaRecruitingNCT06803875Phase 1/2
- Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic TumorsNot yet recruitingNCT06798532
- Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory NeuroblastomaRecruitingNCT06751134Phase 1
- PEEL-224, Vincristine and Temozolomide in Pediatric Solid TumorsRecruitingNCT06721689Phase 1/2
- Risk Model for Metastasis Detection of NeuroblastomaEnrolling by invitationNCT06703944
- A Study on the Efficacy of GD2-CAR T Cells in the Treatment of NeuroblastomaRecruitingNCT06684639Early Phase 1
- Biomarkers of Resiliency In Childhood Cancer SurgeryRecruitingNCT06674811
- Safety and Efficacy of Systemic Allogenic NK Cells in R/R NeuroblastomaRecruitingNCT06674265Phase 1
- Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.RecruitingNCT06631391Phase 1
- Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid TumorsRecruitingNCT06625190Phase 1/2
- Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).RecruitingNCT06607692Phase 1/2
- Adding Of Naxitamb In Induction Therapy For High Risk NeuroblastomaRecruitingNCT06574698
- Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid TumorsRecruitingNCT06541262Phase 1/2
- Tipifarnib and Naxitamab for Relapsed/Refractory NeuroblastomaRecruitingNCT06540963Phase 2
- N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With NeuroblastomaRecruitingNCT06528496Phase 2
- Identification of New Gene Spliceosomes in NeuroblastomaRecruitingNCT06502210
- Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid TumorsRecruitingNCT06500819Phase 1
- Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in NeuroblastomaRecruitingNCT06485947Phase 1
- Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and SarcomasRecruitingNCT06465199Phase 1/2
- NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) TrialRecruitingNCT06450041Phase 2
- Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)RecruitingNCT06395103Phase 1/2
- Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors StratificationRecruitingNCT06296732
- Dinutuximab Beta at the HUS and the Toulouse OncopoleRecruitingNCT06275334
- Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)RecruitingNCT06255210Phase 2
- Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaRecruitingNCT06172296Phase 3
- Induction Chemoimmunotherapy for Patients With High-risk NeuroblastomaRecruitingNCT06071897Phase 3
- A Study of a Vaccine in Combination With Beta-glucan in People With NeuroblastomaRecruitingNCT06057948Phase 2
- Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.Not yet recruitingNCT06047535Phase 4
- A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath TumorsRecruitingNCT06041516Phase 1
- Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed NeuroblastomaRecruitingNCT06013618Phase 2
- MCT for the Harvard/UCSF ROBIN CenterRecruitingNCT06000787Not applicable
- Determining Patterns In Study Experiences of Neuroblastoma PatientsNot yet recruitingNCT05918432
- Engineering Immune Organoids to Study Pediatric CancerRecruitingNCT05890781Not applicable
- 18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With NeuroblastomaRecruitingNCT05826158Not applicable
- Use of Virtual Reality for Surgical Planning in NeuroblastomaRecruitingNCT05781919Not applicable
- DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive CancersRecruitingNCT05770037Phase 2/3
- Horse Therapy for Children, Adolescents and Young Adults in Remission From MedulloblastomaRecruitingNCT05755295Not applicable
- APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid TumorsRecruitingNCT05701306Phase 1/2
- GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic RetinoblastomaEnrolling by invitationNCT05650749Phase 1
- SPEARHEAD-3 Pediatric StudyRecruitingNCT05642455Phase 1/2
- TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory NeuroblastomaRecruitingNCT05562024Phase 1
- Naxitamab Added to Induction for Newly Diagnosed High-Risk NeuroblastomaRecruitingNCT05489887Phase 2
- Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed OsteosarcomaRecruitingNCT05400603Phase 1
- Tucidinostat Plus Etoposide in the Treatment of Neuroblastoma in Childhood.RecruitingNCT05338541Phase 1
- Allogeneic Hematopoietic Stem Cell Transplantation for 4/M NeuroblastomaNot yet recruitingNCT05303727Phase 2
- Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic CancersRecruitingNCT05296564Phase 1/2
- Immunotherapy With Dinutuximab Beta in Combination With Chemotherapy for the Treatment of Patients With Primary Neuroblastoma Refractory to Standard Therapy and With Relapsed or Progressive DiseaseRecruitingNCT05272371Phase 1
- SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic TumoursRecruitingNCT05192980Not applicable
- A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid TumorsRecruitingNCT05135975Phase 2
- 18F-MFBG PET/CT in the Evaluation of Neural Crest TumorRecruitingNCT05069220Early Phase 1
- A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With NeuroblastomaRecruitingNCT04936529Phase 2
- 177Lutetium-DOTATATE in Children with Primary Refractory or Relapsed High-risk NeuroblastomaRecruitingNCT04903899Phase 2
- Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing SarcomaRecruitingNCT04901702Phase 1/2
- B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)RecruitingNCT04897321Phase 1
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsRecruitingNCT04851119Phase 1/2
- 18F-DOPA II - PET Imaging OptimizationRecruitingNCT04706910Phase 3
- 4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating NeuroblastomaNot yet recruitingNCT04637503Phase 1/2
- 68Ga-DOTATATE Neuroblastoma Imaging PilotRecruitingNCT04559217Phase 2
- Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS MalignanciesRecruitingNCT04308330Phase 1
- Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory OsteosarcomaRecruitingNCT03721068Phase 1
- An Intermediate Expanded Use Trial of DFMOAvailableNCT03581240
- International PPB/DICER1 RegistryRecruitingNCT03382158